Scalable production of adeno‐associated virus type 2 vectors via suspension transfection
- 18 April 2006
- journal article
- research article
- Published by Wiley in Biotechnology & Bioengineering
- Vol. 94 (3) , 416-430
- https://doi.org/10.1002/bit.20776
Abstract
Vectors derived from adeno‐associated virus type 2 (AAV2) are promising gene delivery vehicles, but it is still challenging to get the large number of recombinant adeno‐associated virus (rAAV) particles required for large animal and clinical studies. Current transfection technology requires adherent cultures of HEK 293 cells that can only be expanded by preparing multiple culture plates. A single large‐scale suspension culture could replace these multiple culture preparations, but there is currently no effective co‐transfection scheme for generating rAAV from cells in suspension culture. Here, we weaned HEK 293 cells to suspension culture using hydrogel‐coated six‐well culture plates and established an efficient transfection strategy suitable for these cells. Then the cultures were gradually scaled up. We used linear polyethylenimine (PEI) to mediate transfection and obtained high transfection efficiencies ranging from 54% to 99%, thereby allowing efficient generation of rAAV vectors. Up to 1013 rAAV particles and, more importantly, up to 1011 infectious particles were generated from a 2‐L bioreactor culture. The suspension‐transfection strategy of this study facilitates the homogeneous preparation of rAAV at a large scale, and holds further potential as the basis for establishing a manufacturing process in a larger bioreactor.Keywords
This publication has 51 references indexed in Scilit:
- A Novel Gene Expression Control System and Its Use in Stable, High-Titer 293 Cell-Based Adeno-Associated Virus Packaging Cell LinesJournal of Virology, 2002
- A Versatile and Scalable Two-Step Ion-Exchange Chromatography Process for the Purification of Recombinant Adeno-associated Virus Serotypes-2 and -5Molecular Therapy, 2002
- Gene therapy for hemophiliaThe Journal of Gene Medicine, 2001
- Optimised helper virus-free production of high-quality adeno-associated virus vectorsThe Journal of Gene Medicine, 2001
- Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genomeThe Journal of Gene Medicine, 2000
- High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and CapGene Therapy, 1999
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirusGene Therapy, 1999
- High-Titer Adeno-Associated Viral Vectors from a Rep/Cap Cell Line and Hybrid Shuttle VirusHuman Gene Therapy, 1998
- Factors Influencing Recombinant Adeno-Associated Virus ProductionHuman Gene Therapy, 1998